Ann Partridge has been named Interim Chair of Medical Oncology for Dana-Farber
Dr. Ann H. Partridge, MD, MPH, is a prominent medical oncologist specializing in breast cancer. She serves as Vice Chair of Medical Oncology at Dana-Farber Cancer Institute, where she founded and directs the Program for Young Adults with Breast Cancer and the Adult Survivorship Program. Holding the Eric P. Winer, MD, Chair in Breast Cancer Research, she is also a Senior Physician at Dana-Farber and a Professor of Medicine at Harvard Medical School.
Recently, Partridge has been named Interim Chair of Medical Oncology for Dana-Farber.
On this occasion, Dana-Farber Cancer Institute shared a post on LinkedIn:
“Ann Partridge, MD, MPH, has been named Interim Chair of Medical Oncology for Dana-Farber, effective Oct. 1. She will succeed Benjamin L. Ebert, MD, PhD, as he assumes the role of Dana-Farber President and CEO on Oct. 1.
In her new role, Dr. Partridge will oversee more than 300 faculty and more than 80 cancer research laboratories, and will lead the strategic direction for the department’s clinical, research, and educational initiatives.”
More posts featuring Ann Partridge and Dana-Farber Cancer Institute on OncoDaily.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023